We thank all our partners for their kind support.

Platinum Partner 2018

Logo AbbVie

AbbVie, formed in 2013 following the separation from Abbott, has partnered with EFCNI since 2008 supporting the organization’s efforts to increase awareness of the many challenges associated with preterm birth and improving the quality of care available for preterm infants. 

AbbVie aims to help patients live healthier lives and collaborate with diverse stakeholders on sustainable healthcare solutions for patients, caregivers and societies around the world. 

AbbVie (NYSE:ABBV) is a global, research-based biopharmaceutical company whose mission is to use its expertise, dedicated people and unique approach to innovation to develop and market advanced therapies that address some of the world’s most complex and serious diseases. The company employs nearly 21,000 people worldwide and markets medicines in more than 170 countries.

Premium Partners 2018

Baxter as been assisting clinicians in treating patients’ diverse nutrient needs since the 1940s, when the company first introduced liquid proteins in the form of amino acids. Since then, Baxter has continued to advance parenteral nutrition (PN) therapy. As an example, Baxter pioneered the world’s first triple-chamber system internationally for IV nutrition, which provides many of the essential ingredients of balanced nutrition – protein, carbohydrates, lipids and electrolytes in a single container – simplifying the preparation of PN for patients. 

Today, Baxter provides one of the broadest PN portfolios globally, which includes premix IV solutions, vitamins and lipids, as well as pharmacy workflow management, labeling, compounding technology and enteral nutrition syringes and accessories. Baxter’s employees worldwide are building upon the company’s rich heritage of medical breakthroughs to advance the next generation of healthcare innovations for new standards of care.

The fantastic progress in the delivery and treatment of small and very small preterm infants presents new challenges for nutrition and care. Nestlé Nutrition has always been invested in the research and development of products for specific nutritional needs. It has therefore created the world’s largest research center in the field and an international network of collaboration with doctors and scientists. Resulting solutions can be tailored to specific nutritional requirements, as is the case with the special stage concept, elaborated to suit the changing needs of a developing preterm infant. Nestlé Nutrition has also developed a protein (hydrolysate) that provides allergy prevention proven to be effective.

The first small patient ever given Henri Nestlé’s “infants’ flour” was, in 1867, a preterm infant the doctors had already given up on. Little Charles Wanner went on to live for more than sixty years.

Since 1984, AVENT has been designing and manufacturing products that are inspired by nature and have been developed through extensive research and clinical trials. Now, as part of the Philips Group, the new Philips AVENT will continue to produce innovative solutions that make feeding and caring for your baby’s health and safety easier. Philips AVENT is delighted to be the No. 1 recommended brand by UK mums* with its products loved by mums and babies across the UK. Philips AVENT believes that breastfeeding is the best method of nutrition for babies and that women should be given as much information and education as possible regarding the benefits of breast milk. Philips AVENT believes that it is every mother’s right to make her own decision on how she feeds her baby – bottle, breast or a combination of both – and Philips AVENT will support her in whatever choice she makes.

Shire’s strategy is to focus on developing and marketing innovative specialty medicines to meet significant unmet patient needs. The company focuses on providing treatments in Neuroscience, Rare Diseases, Gastrointestinal, and Internal Medicine and is developing treatments for symptomatic conditions treated by specialist physicians in other targeted therapeutic areas, such as Ophthalmology.

Silver Partners 2018

Founded in 1989, Natus Medical Inc. is a leading manufacturer of medical devices and software and a service provider for the Newborn Care, Neurology, Sleep, Hearing and Balance markets. Natus products are used in hospitals, clinics and laboratories worldwide. Our mission is to improve outcomes and patient care in target markets through innovative screening, diagnostic and treatment solutions.

Products manufactured by Natus are sold through a combination of direct sales force and worldwide distribution partners. Natus products are sold and supported in over 100 countries. Among the many benefits provided to our customers is the NeonatalCareAcademy as well as the NERVE Center, Natus’ education portal supporting our customers with ongoing product and clinical training and education.

Royal DSM is a global science-based company active in health, nutrition and materials. By connecting its unique competences in Life Sciences and Materials Sciences DSM is driving economic prosperity, environmental progress and social advances to create sustainable value for all stakeholders simultaneously. DSM delivers innovative solutions that nourish, protect and improve performance in global markets such as food and dietary supplements, personal care, feed, medical devices, automotive, paints, electrical and electronics, life protection, alternative energy and bio-based materials. DSM and its associated companies deliver annual net sales of about €10 billion with approximately 25,000 employees. The company is listed on Euronext Amsterdam.

Bronze Partner 2018

Since 1962, Vygon grants a preeminent importance to the respect of patients. However small they are.

Because premature neonates require our greatest attention, Vygon focuses its efforts in developing single-use products in several fields: respiratory tract, nutrition, vascular access, etc. Innovation is the key to offer to a very fragile infant the best start in life.

Present in more than 100 countries, the French family-owned company is committed to providing health-care professionals with the best possible solutions to treat and care for their patients.

Helping a preterm infant to grow up in good conditions: that is the challenge we face every day!

How to become a partner

You would like to support us in decreasing the preterm birth rate and in helping the smallest of the small as well as their families and you would like to show it?

Become a Partner of EFCNI!

Please do not hesitate to contact our Chairwoman of the Executive Board, Mrs. Silke Mader, for further information.

We thank all our partners for their kind support.

Premium Partners 2017

Logo AbbVie

AbbVie, formed in 2013 following the separation from Abbott, has partnered with EFCNI since 2008 supporting the organization’s efforts to increase awareness of the many challenges associated with preterm birth and improving the quality of care available for preterm infants. 

AbbVie aims to help patients live healthier lives and collaborate with diverse stakeholders on sustainable healthcare solutions for patients, caregivers and societies around the world. 

AbbVie (NYSE:ABBV) is a global, research-based biopharmaceutical company whose mission is to use its expertise, dedicated people and unique approach to innovation to develop and market advanced therapies that address some of the world’s most complex and serious diseases. The company employs nearly 21,000 people worldwide and markets medicines in more than 170 countries.

Baxter has been assisting clinicians in treating patients’ diverse nutrient needs since the 1940s, when the company first introduced liquid proteins in the form of amino acids. Since then, Baxter has continued to advance parenteral nutrition (PN) therapy. As an example, Baxter pioneered the world’s first triple-chamber system internationally for IV nutrition, which provides many of the essential ingredients of balanced nutrition – protein, carbohydrates, lipids and electrolytes in a single container – simplifying the preparation of PN for patients. 

Today, Baxter provides one of the broadest PN portfolios globally, which includes premix IV solutions, vitamins and lipids, as well as pharmacy workflow management, labeling, compounding technology and enteral nutrition syringes and accessories. Baxter’s employees worldwide are building upon the company’s rich heritage of medical breakthroughs to advance the next generation of healthcare innovations for new standards of care.

Founded in 1989, Natus Medical Inc. is a leading manufacturer of medical devices and software and a service provider for the Newborn Care, Neurology, Sleep, Hearing and Balance markets. Natus products are used in hospitals, clinics and laboratories worldwide. Our mission is to improve outcomes and patient care in target markets through innovative screening, diagnostic and treatment solutions.

Products manufactured by Natus are sold through a combination of direct sales force and worldwide distribution partners. Natus products are sold and supported in over 100 countries. Among the many benefits provided to our customers is the NeonatalCareAcademy as well as the NERVE Center, Natus’ education portal supporting our customers with ongoing product and clinical training and education.

The fantastic progress in the delivery and treatment of small and very small preterm infants presents new challenges for nutrition and care. Nestlé Nutrition has always been invested in the research and development of products for specific nutritional needs. It has therefore created the world’s largest research center in the field and an international network of collaboration with doctors and scientists. Resulting solutions can be tailored to specific nutritional requirements, as is the case with the special stage concept, elaborated to suit the changing needs of a developing preterm infant. Nestlé Nutrition has also developed a protein (hydrolysate) that provides allergy prevention proven to be effective.

The first small patient ever given Henri Nestlé’s “infants’ flour” was, in 1867, a preterm infant the doctors had already given up on. Little Charles Wanner went on to live for more than sixty years.

Since 1984, AVENT has been designing and manufacturing products that are inspired by nature and have been developed through extensive research and clinical trials. Now, as part of the Philips Group, the new Philips AVENT will continue to produce innovative solutions that make feeding and caring for your baby’s health and safety easier. Philips AVENT is delighted to be the No. 1 recommended brand by UK mums* with its products loved by mums and babies across the UK. Philips AVENT believes that breastfeeding is the best method of nutrition for babies and that women should be given as much information and education as possible regarding the benefits of breast milk. Philips AVENT believes that it is every mother’s right to make her own decision on how she feeds her baby – bottle, breast or a combination of both – and Philips AVENT will support her in whatever choice she makes.

Shire’s strategy is to focus on developing and marketing innovative specialty medicines to meet significant unmet patient needs. The company focuses on providing treatments in Neuroscience, Rare Diseases, Gastrointestinal, and Internal Medicine and is developing treatments for symptomatic conditions treated by specialist physicians in other targeted therapeutic areas, such as Ophthalmology.

Silver Partner 2017

Royal DSM is a global science-based company active in health, nutrition and materials. By connecting its unique competences in Life Sciences and Materials Sciences DSM is driving economic prosperity, environmental progress and social advances to create sustainable value for all stakeholders simultaneously. DSM delivers innovative solutions that nourish, protect and improve performance in global markets such as food and dietary supplements, personal care, feed, medical devices, automotive, paints, electrical and electronics, life protection, alternative energy and bio-based materials. DSM and its associated companies deliver annual net sales of about €10 billion with approximately 25,000 employees. The company is listed on Euronext Amsterdam.

Bronze Partner 2017

Since 1962, Vygon grants a preeminent importance to the respect of patients. However small they are.

Because premature neonates require our greatest attention, Vygon focuses its efforts in developing single-use products in several fields: respiratory tract, nutrition, vascular access, etc. Innovation is the key to offer to a very fragile infant the best start in life.

Present in more than 100 countries, the French family-owned company is committed to providing health-care professionals with the best possible solutions to treat and care for their patients.

Helping a preterm infant to grow up in good conditions: that is the challenge we face every day!

How to become a partner

You would like to support us in decreasing the preterm birth rate and in helping the smallest of the small as well as their families and you would like to show it?

Become a Partner of EFCNI!

Please do not hesitate to contact our Chairwoman of the Executive Board, Mrs. Silke Mader, for further information.

We thank all our partners for their kind support.

Premium Partners 2016

Logo AbbVie

AbbVie, formed in 2013 following the separation from Abbott, has partnered with EFCNI since 2008 supporting the organization’s efforts to increase awareness of the many challenges associated with preterm birth and improving the quality of care available for preterm infants. 

AbbVie aims to help patients live healthier lives and collaborate with diverse stakeholders on sustainable healthcare solutions for patients, caregivers and societies around the world. 

AbbVie (NYSE:ABBV) is a global, research-based biopharmaceutical company whose mission is to use its expertise, dedicated people and unique approach to innovation to develop and market advanced therapies that address some of the world’s most complex and serious diseases. The company employs nearly 21,000 people worldwide and markets medicines in more than 170 countries.

Founded in 1989, Natus Medical Inc. is a leading manufacturer of medical devices and software and a service provider for the Newborn Care, Neurology, Sleep, Hearing and Balance markets. Natus products are used in hospitals, clinics and laboratories worldwide. Our mission is to improve outcomes and patient care in target markets through innovative screening, diagnostic and treatment solutions.

Products manufactured by Natus are sold through a combination of direct sales force and worldwide distribution partners. Natus products are sold and supported in over 100 countries. Among the many benefits provided to our customers is the NeonatalCareAcademy as well as the NERVE Center, Natus’ education portal supporting our customers with ongoing product and clinical training and education.

The fantastic progress in the delivery and treatment of small and very small preterm infants presents new challenges for nutrition and care. Nestlé Nutrition has always been invested in the research and development of products for specific nutritional needs. It has therefore created the world’s largest research center in the field and an international network of collaboration with doctors and scientists. Resulting solutions can be tailored to specific nutritional requirements, as is the case with the special stage concept, elaborated to suit the changing needs of a developing preterm infant. Nestlé Nutrition has also developed a protein (hydrolysate) that provides allergy prevention proven to be effective.

The first small patient ever given Henri Nestlé’s “infants’ flour” was, in 1867, a preterm infant the doctors had already given up on. Little Charles Wanner went on to live for more than sixty years.

Since 1984, AVENT has been designing and manufacturing products that are inspired by nature and have been developed through extensive research and clinical trials. Now, as part of the Philips Group, the new Philips AVENT will continue to produce innovative solutions that make feeding and caring for your baby’s health and safety easier. Philips AVENT is delighted to be the No. 1 recommended brand by UK mums* with its products loved by mums and babies across the UK. Philips AVENT believes that breastfeeding is the best method of nutrition for babies and that women should be given as much information and education as possible regarding the benefits of breast milk. Philips AVENT believes that it is every mother’s right to make her own decision on how she feeds her baby – bottle, breast or a combination of both – and Philips AVENT will support her in whatever choice she makes.

Silver Partner 2016

Shire’s strategy is to focus on developing and marketing innovative specialty medicines to meet significant unmet patient needs. The company focuses on providing treatments in Neuroscience, Rare Diseases, Gastrointestinal, and Internal Medicine and is developing treatments for symptomatic conditions treated by specialist physicians in other targeted therapeutic areas, such as Ophthalmology.

Bronze Partner 2016

Since 1962, Vygon grants a preeminent importance to the respect of patients. However small they are.

Because premature neonates require our greatest attention, Vygon focuses its efforts in developing single-use products in several fields: respiratory tract, nutrition, vascular access, etc. Innovation is the key to offer to a very fragile infant the best start in life.

Present in more than 100 countries, the French family-owned company is committed to providing health-care professionals with the best possible solutions to treat and care for their patients.

Helping a preterm infant to grow up in good conditions: that is the challenge we face every day!

How to become a partner

You would like to support us in decreasing the preterm birth rate and in helping the smallest of the small as well as their families and you would like to show it?

Become a Partner of EFCNI!

Please do not hesitate to contact our Chairwoman of the Executive Board, Mrs. Silke Mader, for further information.

We thank all our partners for their kind support.

Premium Partners 2015

Logo AbbVie

AbbVie, formed in 2013 following the separation from Abbott, has partnered with EFCNI since 2008 supporting the organization’s efforts to increase awareness of the many challenges associated with preterm birth and improving the quality of care available for preterm infants. 

AbbVie aims to help patients live healthier lives and collaborate with diverse stakeholders on sustainable healthcare solutions for patients, caregivers and societies around the world. 

AbbVie (NYSE:ABBV) is a global, research-based biopharmaceutical company whose mission is to use its expertise, dedicated people and unique approach to innovation to develop and market advanced therapies that address some of the world’s most complex and serious diseases. The company employs nearly 21,000 people worldwide and markets medicines in more than 170 countries.

The fantastic progress in the delivery and treatment of small and very small preterm infants presents new challenges for nutrition and care. Nestlé Nutrition has always been invested in the research and development of products for specific nutritional needs. It has therefore created the world’s largest research center in the field and an international network of collaboration with doctors and scientists. Resulting solutions can be tailored to specific nutritional requirements, as is the case with the special stage concept, elaborated to suit the changing needs of a developing preterm infant. Nestlé Nutrition has also developed a protein (hydrolysate) that provides allergy prevention proven to be effective.

The first small patient ever given Henri Nestlé’s “infants’ flour” was, in 1867, a preterm infant the doctors had already given up on. Little Charles Wanner went on to live for more than sixty years.

Since 1984, AVENT has been designing and manufacturing products that are inspired by nature and have been developed through extensive research and clinical trials. Now, as part of the Philips Group, the new Philips AVENT will continue to produce innovative solutions that make feeding and caring for your baby’s health and safety easier. Philips AVENT is delighted to be the No. 1 recommended brand by UK mums* with its products loved by mums and babies across the UK. Philips AVENT believes that breastfeeding is the best method of nutrition for babies and that women should be given as much information and education as possible regarding the benefits of breast milk. Philips AVENT believes that it is every mother’s right to make her own decision on how she feeds her baby – bottle, breast or a combination of both – and Philips AVENT will support her in whatever choice she makes.

Premium Project Partner 2015

Dräger is an international leader in the fields of medical and safety technology.

The family-owned company was founded in Lübeck, Germany, in 1889. Over the past five generations, Dräger has evolved into a publicly traded, worldwide group.

The current product range of the medical division includes anesthesia workstations, ventilators for emergency, critical care as well as warming therapy for premature infants. Patient monitoring, IT solutions, accessories and consumables, ceiling supply units, light systems and central supply systems for medical gases complete the portfolio.

Dräger has about 11,000 employees worldwide and is currently present in more than 190 countries. The company has sales and service subsidiaries in over 40 countries. Its development and production facilities are based in Germany, Great Britain, Sweden, South Africa, the USA, Brazil, the Czech Republic and China.

Silver Partner 2015

Shire’s strategy is to focus on developing and marketing innovative specialty medicines to meet significant unmet patient needs. The company focuses on providing treatments in Neuroscience, Rare Diseases, Gastrointestinal, and Internal Medicine and is developing treatments for symptomatic conditions treated by specialist physicians in other targeted therapeutic areas, such as Ophthalmology.

Bronze Partner 2015

Since 1962, Vygon grants a preeminent importance to the respect of patients. However small they are.

Because premature neonates require our greatest attention, Vygon focuses its efforts in developing single-use products in several fields: respiratory tract, nutrition, vascular access, etc. Innovation is the key to offer to a very fragile infant the best start in life.

Present in more than 100 countries, the French family-owned company is committed to providing health-care professionals with the best possible solutions to treat and care for their patients.

Helping a preterm infant to grow up in good conditions: that is the challenge we face every day!

How to become a partner

You would like to support us in decreasing the preterm birth rate and in helping the smallest of the small as well as their families and you would like to show it?

Become a Partner of EFCNI!

Please do not hesitate to contact our Chairwoman of the Executive Board, Mrs. Silke Mader, for further information.

We thank all our partners for their kind support.

Premium Partners 2014

Logo AbbVie

AbbVie, formed in 2013 following the separation from Abbott, has partnered with EFCNI since 2008 supporting the organization’s efforts to increase awareness of the many challenges associated with preterm birth and improving the quality of care available for preterm infants. 

AbbVie aims to help patients live healthier lives and collaborate with diverse stakeholders on sustainable healthcare solutions for patients, caregivers and societies around the world. 

AbbVie (NYSE:ABBV) is a global, research-based biopharmaceutical company whose mission is to use its expertise, dedicated people and unique approach to innovation to develop and market advanced therapies that address some of the world’s most complex and serious diseases. The company employs nearly 21,000 people worldwide and markets medicines in more than 170 countries.

The fantastic progress in the delivery and treatment of small and very small preterm infants presents new challenges for nutrition and care. Nestlé Nutrition has always been invested in the research and development of products for specific nutritional needs. It has therefore created the world’s largest research center in the field and an international network of collaboration with doctors and scientists. Resulting solutions can be tailored to specific nutritional requirements, as is the case with the special stage concept, elaborated to suit the changing needs of a developing preterm infant. Nestlé Nutrition has also developed a protein (hydrolysate) that provides allergy prevention proven to be effective.

The first small patient ever given Henri Nestlé’s “infants’ flour” was, in 1867, a preterm infant the doctors had already given up on. Little Charles Wanner went on to live for more than sixty years.

Since 1984, AVENT has been designing and manufacturing products that are inspired by nature and have been developed through extensive research and clinical trials. Now, as part of the Philips Group, the new Philips AVENT will continue to produce innovative solutions that make feeding and caring for your baby’s health and safety easier. Philips AVENT is delighted to be the No. 1 recommended brand by UK mums* with its products loved by mums and babies across the UK. Philips AVENT believes that breastfeeding is the best method of nutrition for babies and that women should be given as much information and education as possible regarding the benefits of breast milk. Philips AVENT believes that it is every mother’s right to make her own decision on how she feeds her baby – bottle, breast or a combination of both – and Philips AVENT will support her in whatever choice she makes.

Premium Project Partner 2014

Dräger is an international leader in the fields of medical and safety technology.

The family-owned company was founded in Lübeck, Germany, in 1889. Over the past five generations, Dräger has evolved into a publicly traded, worldwide group.

The current product range of the medical division includes anesthesia workstations, ventilators for emergency, critical care as well as warming therapy for premature infants. Patient monitoring, IT solutions, accessories and consumables, ceiling supply units, light systems and central supply systems for medical gases complete the portfolio.

Dräger has about 11,000 employees worldwide and is currently present in more than 190 countries. The company has sales and service subsidiaries in over 40 countries. Its development and production facilities are based in Germany, Great Britain, Sweden, South Africa, the USA, Brazil, the Czech Republic and China.

Silver Partner 2014

Shire’s strategy is to focus on developing and marketing innovative specialty medicines to meet significant unmet patient needs. The company focuses on providing treatments in Neuroscience, Rare Diseases, Gastrointestinal, and Internal Medicine and is developing treatments for symptomatic conditions treated by specialist physicians in other targeted therapeutic areas, such as Ophthalmology.

Bronze Partner 2014

Medela passionately transforms research findings into the most advanced breastpumping technology. For almost 50 years, Medela has helped to enhance babies‘ health through the life-giving benefits of breastmilk and supports mothers during their breastfeeding experience – making it as safe and easy as possible. Medela strives to understand nature and has become a leading expert in breastfeeding over the years.

How to become a partner

You would like to support us in decreasing the preterm birth rate and in helping the smallest of the small as well as their families and you would like to show it?

Become a Partner of EFCNI!

Please do not hesitate to contact our Chairwoman of the Executive Board, Mrs. Silke Mader, for further information.

We thank all our partners for their kind support.

Premium Partners 2013

Logo AbbVie

AbbVie, formed in 2013 following the separation from Abbott, has partnered with EFCNI since 2008 supporting the organization’s efforts to increase awareness of the many challenges associated with preterm birth and improving the quality of care available for preterm infants. 

AbbVie aims to help patients live healthier lives and collaborate with diverse stakeholders on sustainable healthcare solutions for patients, caregivers and societies around the world. 

AbbVie (NYSE:ABBV) is a global, research-based biopharmaceutical company whose mission is to use its expertise, dedicated people and unique approach to innovation to develop and market advanced therapies that address some of the world’s most complex and serious diseases. The company employs nearly 21,000 people worldwide and markets medicines in more than 170 countries.

The fantastic progress in the delivery and treatment of small and very small preterm infants presents new challenges for nutrition and care. Nestlé Nutrition has always been invested in the research and development of products for specific nutritional needs. It has therefore created the world’s largest research center in the field and an international network of collaboration with doctors and scientists. Resulting solutions can be tailored to specific nutritional requirements, as is the case with the special stage concept, elaborated to suit the changing needs of a developing preterm infant. Nestlé Nutrition has also developed a protein (hydrolysate) that provides allergy prevention proven to be effective.

The first small patient ever given Henri Nestlé’s “infants’ flour” was, in 1867, a preterm infant the doctors had already given up on. Little Charles Wanner went on to live for more than sixty years.

PerkinElmer is a specialist in the identification of disorders during pregnancy and in the first days of a baby’s life. Our focus is on just those diseases where early detection can allow effective treatment. Over the past 25 years PerkinElmer screening tests have been used to check many millions of pregnancies or newborn babies, and it is estimated that currently some 50 babies per day, somewhere in the world are able to move forward to a healthy childhood because their disorder was detected in time by a PerkinElmer test.

During pregnancy, we have pioneered new screening methods for pre-eclampsia which will identify high risk pregnancies already during the first trimester. There is growing evidence that early treatment of the high risk cases can delay or prevent the development of the disease.

Premium Project Partner 2013

Dräger is an international leader in the fields of medical and safety technology.

The family-owned company was founded in Lübeck, Germany, in 1889. Over the past five generations, Dräger has evolved into a publicly traded, worldwide group.

The current product range of the medical division includes anesthesia workstations, ventilators for emergency, critical care as well as warming therapy for premature infants. Patient monitoring, IT solutions, accessories and consumables, ceiling supply units, light systems and central supply systems for medical gases complete the portfolio.

Dräger has about 11,000 employees worldwide and is currently present in more than 190 countries. The company has sales and service subsidiaries in over 40 countries. Its development and production facilities are based in Germany, Great Britain, Sweden, South Africa, the USA, Brazil, the Czech Republic and China.

Bronze Partner 2013

Medela passionately transforms research findings into the most advanced breastpumping technology. For almost 50 years, Medela has helped to enhance babies‘ health through the life-giving benefits of breastmilk and supports mothers during their breastfeeding experience – making it as safe and easy as possible. Medela strives to understand nature and has become a leading expert in breastfeeding over the years.

How to become a partner

You would like to support us in decreasing the preterm birth rate and in helping the smallest of the small as well as their families and you would like to show it?

Become a Partner of EFCNI!

Please do not hesitate to contact our Chairwoman of the Executive Board, Mrs. Silke Mader, for further information.

We thank all our partners for their kind support.

Premium Partners 2012

Abbott has partnered with EFCNI since 2008, supporting the organization’s efforts to increase awareness of the many challenges associated with preterm birth and improving the quality of care available for preterm infants.

Abbott is committed to bringing together diverse stakeholders to find new solutions for patients, caregivers and societies around the world.

Abbott is a global, broad-based health care company devoted to the discovery, development, manufacture and marketing of pharmaceuticals and medical products, including nutritionals, devices and diagnostics. The company employs nearly 90,000 people and markets its products in more than 130 countries.

The fantastic progress in the delivery and treatment of small and very small preterm infants presents new challenges for nutrition and care. Nestlé Nutrition has always been invested in the research and development of products for specific nutritional needs. It has therefore created the world’s largest research center in the field and an international network of collaboration with doctors and scientists. Resulting solutions can be tailored to specific nutritional requirements, as is the case with the special stage concept, elaborated to suit the changing needs of a developing preterm infant. Nestlé Nutrition has also developed a protein (hydrolysate) that provides allergy prevention proven to be effective.

The first small patient ever given Henri Nestlé’s “infants’ flour” was, in 1867, a preterm infant the doctors had already given up on. Little Charles Wanner went on to live for more than sixty years.

PerkinElmer is a specialist in the identification of disorders during pregnancy and in the first days of a baby’s life. Our focus is on just those diseases where early detection can allow effective treatment. Over the past 25 years PerkinElmer screening tests have been used to check many millions of pregnancies or newborn babies, and it is estimated that currently some 50 babies per day, somewhere in the world are able to move forward to a healthy childhood because their disorder was detected in time by a PerkinElmer test.

During pregnancy, we have pioneered new screening methods for pre-eclampsia which will identify high risk pregnancies already during the first trimester. There is growing evidence that early treatment of the high risk cases can delay or prevent the development of the disease.

Premium Project Partner 2012

Dräger is an international leader in the fields of medical and safety technology.

The family-owned company was founded in Lübeck, Germany, in 1889. Over the past five generations, Dräger has evolved into a publicly traded, worldwide group.

The current product range of the medical division includes anesthesia workstations, ventilators for emergency, critical care as well as warming therapy for premature infants. Patient monitoring, IT solutions, accessories and consumables, ceiling supply units, light systems and central supply systems for medical gases complete the portfolio.

Dräger has about 11,000 employees worldwide and is currently present in more than 190 countries. The company has sales and service subsidiaries in over 40 countries. Its development and production facilities are based in Germany, Great Britain, Sweden, South Africa, the USA, Brazil, the Czech Republic and China.

Bronze Partner 2012

Medela passionately transforms research findings into the most advanced breastpumping technology. For almost 50 years, Medela has helped to enhance babies‘ health through the life-giving benefits of breastmilk and supports mothers during their breastfeeding experience – making it as safe and easy as possible. Medela strives to understand nature and has become a leading expert in breastfeeding over the years.

How to become a partner

You would like to support us in decreasing the preterm birth rate and in helping the smallest of the small as well as their families and you would like to show it?

Become a Partner of EFCNI!

Please do not hesitate to contact our Chairwoman of the Executive Board, Mrs. Silke Mader, for further information.

We thank all our partners for their kind support.

Premium Partners 2011

Abbott has partnered with EFCNI since 2008, supporting the organization’s efforts to increase awareness of the many challenges associated with preterm birth and improving the quality of care available for preterm infants.

Abbott is committed to bringing together diverse stakeholders to find new solutions for patients, caregivers and societies around the world.

Abbott is a global, broad-based health care company devoted to the discovery, development, manufacture and marketing of pharmaceuticals and medical products, including nutritionals, devices and diagnostics. The company employs nearly 90,000 people and markets its products in more than 130 countries.

The fantastic progress in the delivery and treatment of small and very small preterm infants presents new challenges for nutrition and care. Nestlé Nutrition has always been invested in the research and development of products for specific nutritional needs. It has therefore created the world’s largest research center in the field and an international network of collaboration with doctors and scientists. Resulting solutions can be tailored to specific nutritional requirements, as is the case with the special stage concept, elaborated to suit the changing needs of a developing preterm infant. Nestlé Nutrition has also developed a protein (hydrolysate) that provides allergy prevention proven to be effective.

The first small patient ever given Henri Nestlé’s “infants’ flour” was, in 1867, a preterm infant the doctors had already given up on. Little Charles Wanner went on to live for more than sixty years.

Premium Project Partner 2011

Dräger is an international leader in the fields of medical and safety technology.

The family-owned company was founded in Lübeck, Germany, in 1889. Over the past five generations, Dräger has evolved into a publicly traded, worldwide group.

The current product range of the medical division includes anesthesia workstations, ventilators for emergency, critical care as well as warming therapy for premature infants. Patient monitoring, IT solutions, accessories and consumables, ceiling supply units, light systems and central supply systems for medical gases complete the portfolio.

Dräger has about 11,000 employees worldwide and is currently present in more than 190 countries. The company has sales and service subsidiaries in over 40 countries. Its development and production facilities are based in Germany, Great Britain, Sweden, South Africa, the USA, Brazil, the Czech Republic and China.

Bronze Partner 2011

Medela passionately transforms research findings into the most advanced breastpumping technology. For almost 50 years, Medela has helped to enhance babies‘ health through the life-giving benefits of breastmilk and supports mothers during their breastfeeding experience – making it as safe and easy as possible. Medela strives to understand nature and has become a leading expert in breastfeeding over the years.

How to become a partner

You would like to support us in decreasing the preterm birth rate and in helping the smallest of the small as well as their families and you would like to show it?

Become a Partner of EFCNI!

Please do not hesitate to contact our Chairwoman of the Executive Board, Mrs. Silke Mader, for further information.

We thank all our partners for their kind support.

Premium Partners 2010

Abbott has partnered with EFCNI since 2008, supporting the organization’s efforts to increase awareness of the many challenges associated with preterm birth and improving the quality of care available for preterm infants.

Abbott is committed to bringing together diverse stakeholders to find new solutions for patients, caregivers and societies around the world.

Abbott is a global, broad-based health care company devoted to the discovery, development, manufacture and marketing of pharmaceuticals and medical products, including nutritionals, devices and diagnostics. The company employs nearly 90,000 people and markets its products in more than 130 countries.

The fantastic progress in the delivery and treatment of small and very small preterm infants presents new challenges for nutrition and care. Nestlé Nutrition has always been invested in the research and development of products for specific nutritional needs. It has therefore created the world’s largest research center in the field and an international network of collaboration with doctors and scientists. Resulting solutions can be tailored to specific nutritional requirements, as is the case with the special stage concept, elaborated to suit the changing needs of a developing preterm infant. Nestlé Nutrition has also developed a protein (hydrolysate) that provides allergy prevention proven to be effective.

The first small patient ever given Henri Nestlé’s “infants’ flour” was, in 1867, a preterm infant the doctors had already given up on. Little Charles Wanner went on to live for more than sixty years.

How to become a partner

You would like to support us in decreasing the preterm birth rate and in helping the smallest of the small as well as their families and you would like to show it?

Become a Partner of EFCNI!

Please do not hesitate to contact our Chairwoman of the Executive Board, Mrs. Silke Mader, for further information.

We thank all our partners for their kind support.

Premium Partners 2009

Abbott has partnered with EFCNI since 2008, supporting the organization’s efforts to increase awareness of the many challenges associated with preterm birth and improving the quality of care available for preterm infants.

Abbott is committed to bringing together diverse stakeholders to find new solutions for patients, caregivers and societies around the world.

Abbott is a global, broad-based health care company devoted to the discovery, development, manufacture and marketing of pharmaceuticals and medical products, including nutritionals, devices and diagnostics. The company employs nearly 90,000 people and markets its products in more than 130 countries.

How to become a partner

You would like to support us in decreasing the preterm birth rate and in helping the smallest of the small as well as their families and you would like to show it?

Become a Partner of EFCNI!

Please do not hesitate to contact our Chairwoman of the Executive Board, Mrs. Silke Mader, for further information.

We thank all our partners for their kind support.

Premium Partners 2008

Abbott has partnered with EFCNI since 2008, supporting the organization’s efforts to increase awareness of the many challenges associated with preterm birth and improving the quality of care available for preterm infants.

Abbott is committed to bringing together diverse stakeholders to find new solutions for patients, caregivers and societies around the world.

Abbott is a global, broad-based health care company devoted to the discovery, development, manufacture and marketing of pharmaceuticals and medical products, including nutritionals, devices and diagnostics. The company employs nearly 90,000 people and markets its products in more than 130 countries.

How to become a partner

You would like to support us in decreasing the preterm birth rate and in helping the smallest of the small as well as their families and you would like to show it?

Become a Partner of EFCNI!

Please do not hesitate to contact our Chairwoman of the Executive Board, Mrs. Silke Mader, for further information.